Loading...
Loading...
Elanco Animal Health Incorporated ELAN will consolidate commercial operations for Elanco International and Elanco Europe into one organization under Ramiro Cabral, EVP & President Elanco International.
- The restructuring includes eliminating approximately 380 positions, including about 20% of Elanco's senior management.
- Elanco believes the move will help offset previously disclosed higher cost pressures and maintain its current path to 60% adjusted gross margin by 2023 and 31% adjusted EBITDA margin by 2024.
- Elanco expects to record a Q4 2021 pre-tax charge of $86 million - $94 million for severance costs.
- Reported Q4 net income is expected to reduce by $65 million - $71 million and EPS by approximately $0.13 to $0.15.
- The compensation and benefits savings in 2022 are anticipated to be approximately $60 million, and once fully implemented, are expected to provide annual savings of roughly $70 million.
- There is no change to the 2021 full-year guidance for revenue of $4.73 billion - $4.77 billion, adjusted EBITDA of $1.03 billion - $1.07 billion, and adjusted EPS of $0.97 - $1.03.
- Price Action: ELAN shares are down 1.62% at $29.70 on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in